5.45
price up icon0.93%   0.05
pre-market  Pre-mercato:  5.42   -0.03   -0.55%
loading
Precedente Chiudi:
$5.40
Aprire:
$5.38
Volume 24 ore:
751.01K
Relative Volume:
0.69
Capitalizzazione di mercato:
$916.40M
Reddito:
$596.48M
Utile/perdita netta:
$123.72M
Rapporto P/E:
9.938
EPS:
0.5484
Flusso di cassa netto:
$106.59M
1 W Prestazione:
+0.93%
1M Prestazione:
+15.96%
6M Prestazione:
+50.55%
1 anno Prestazione:
+74.68%
Intervallo 1D:
Value
$5.38
$5.45
Intervallo di 1 settimana:
Value
$5.33
$5.45
Portata 52W:
Value
$2.37
$5.72

Curevac N V Stock (CVAC) Company Profile

Name
Nome
Curevac N V
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
1,088
Name
Cinguettio
Name
Prossima data di guadagno
2025-04-10
Name
Ultimi documenti SEC
Name
CVAC's Discussions on Twitter

Confronta CVAC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CVAC
Curevac N V
5.45 916.40M 596.48M 123.72M 106.59M 0.5484
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Curevac N V Stock (CVAC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-13 Downgrade Jefferies Buy → Hold
2024-04-25 Downgrade Leerink Partners Outperform → Market Perform
2023-06-08 Iniziato SVB Securities Outperform
2023-01-19 Aggiornamento UBS Neutral → Buy
2023-01-09 Aggiornamento Jefferies Hold → Buy
2022-01-21 Downgrade BofA Securities Neutral → Underperform
2022-01-18 Iniziato JMP Securities Mkt Outperform
2021-10-22 Iniziato Deutsche Bank Hold
2021-06-17 Downgrade BofA Securities Buy → Neutral
2021-04-26 Ripresa Credit Suisse Underperform
2021-04-26 Iniziato Guggenheim Neutral
2020-12-10 Downgrade Credit Suisse Neutral → Underperform
2020-09-08 Iniziato BofA Securities Buy
2020-09-08 Iniziato Credit Suisse Neutral
2020-09-08 Iniziato Jefferies Hold
Mostra tutto

Curevac N V Borsa (CVAC) Ultime notizie

pulisher
Jun 18, 2025

Private-Public Deal Momentum Grows, Yet Megamergers Stay Elusive - Investing.com

Jun 18, 2025
pulisher
Jun 17, 2025

BioNTech SE Announces Acquisition of CureVac N.V. - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Germany: BioNTech to acquire CureVac in all-stock transaction - Investors in Healthcare

Jun 17, 2025
pulisher
Jun 16, 2025

BioNTech to Acquire CureVac in Strategic Move - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

CureVac agrees to pay Biontech termination fee Of $43.8 mln under specified circumstances - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

5 Stocks To Ride The German Market RallyCureVac (NASDAQ:CVAC), BioNTech (NASDAQ:BNTX) - Benzinga

Jun 16, 2025
pulisher
Jun 15, 2025

BioNTech to Acquire CureVac in US$1.25 Billion All-Stock Transaction - Global Legal Chronicle

Jun 15, 2025
pulisher
Jun 15, 2025

There's No Escaping CureVac N.V.'s (NASDAQ:CVAC) Muted Revenues Despite A 50% Share Price Rise - simplywall.st

Jun 15, 2025
pulisher
Jun 14, 2025

CureVac’s SWOT analysis: mRNA pioneer’s stock faces pivotal year ahead By Investing.com - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 13, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of - Bluefield Daily Telegraph

Jun 13, 2025
pulisher
Jun 13, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of Shareholders - TradingView

Jun 13, 2025
pulisher
Jun 13, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

BioNTech CureVac Acquisition Boosts Cancer Drug Pipeline - Industry Leaders Magazine

Jun 13, 2025
pulisher
Jun 13, 2025

CureVac (CVAC) Receives Downgrade and Price Target Reduction fro - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

Jefferies cuts CureVac stock rating to hold on BioNTech acquisition By Investing.com - Investing.com UK

Jun 13, 2025
pulisher
Jun 13, 2025

BioNTech: Oddo BHF raises target price - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

BioNTech to buy CureVac in USD 1.25 billion all-stock deal - Medical Dialogues

Jun 13, 2025
pulisher
Jun 13, 2025

CureVac Stock: BioNTech's Billion-Dollar Takeover Bid - sharewise

Jun 13, 2025
pulisher
Jun 12, 2025

BioNTech (BNTX) to Acquire CureVac in $1.25 Billion All-Stock De - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

CureVac (CVAC) Downgraded by Jefferies Analyst After BioNTech Acquisition Agreement | CVAC Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech Announces Strategic Transaction to Acquire CureVac in P - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech Announces Strategic Acquisition of CureVac - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Biontech’s $1.25B Curevac buyout removes mRNA lawsuit uncertainty - BioWorld MedTech

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech to Acquire CureVac in $1.25B Deal - USA Herald

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech's Acquisition Of CureVac Brings Complementary Method To Target Cancer (BNTX) - Seeking Alpha

Jun 12, 2025
pulisher
Jun 12, 2025

5 Firms Guide $1.25B BioNTech, CureVac Oncology Deal - Law360

Jun 12, 2025
pulisher
Jun 12, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, SOAR, MTWO on Behalf of Shareholders - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech to acquire CureVac in $1.25 billion all-stock deal By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech to Acquire CureVac to Expand mRNA Cancer Therapies - N24.com.tr

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech buys mRNA, courtroom rival CureVac in all-stock deal - BioPharma Dive

Jun 12, 2025
pulisher
Jun 12, 2025

Watkins Advises on BioNTech’s US$1.25 Billion Acquisition of CureVac - Latham & Watkins LLP

Jun 12, 2025
pulisher
Jun 12, 2025

M&A News: BioNTech (BNTX) Acquires CureVac in $1.25 Billion Deal - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

CureVac Stock Soars on BioNTech Buyout - Schaeffer's Investment Research

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal - Benzinga

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech Buys CureVac For $1.25 Billion In Stock Deal - Finimize

Jun 12, 2025
pulisher
Jun 12, 2025

CureVac, TELUS International, Oracle And Other Big Stocks Moving Higher On Thursday - Benzinga

Jun 12, 2025
pulisher
Jun 12, 2025

COVID-19 Vaccine Maker BioNTech Buys CureVac as It Aims for Cancer Treatments - Investopedia

Jun 12, 2025
pulisher
Jun 12, 2025

CureVac’s SWOT analysis: mRNA pioneer’s stock faces pivotal year ahead - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

Vaccine developer with Boston HQ acquired for $1.25B - NBC Boston

Jun 12, 2025
pulisher
Jun 12, 2025

CureVac's SWOT analysis: mRNA pioneer's stock faces pivotal year ahead By Investing.com - Investing.com India

Jun 12, 2025
pulisher
Jun 12, 2025

Sector Update: Health Care Stocks Lean Lower Premarket Thursday - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech to Buy CureVac for $1.25 Billion for Cancer Boost - Bloomberg

Jun 12, 2025
pulisher
Jun 12, 2025

M&A News: BioNTech Snaps Up CureVac in $1.25B Deal to Supercharge Cancer Pipeline - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Germany's BioNTech to buy CureVac to boost cancer research - Yahoo

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech to buy former Boston Covid vaccine rival for $1.25B - The Business Journals

Jun 12, 2025
pulisher
Jun 12, 2025

CVAC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CureVac N.V. Is Fair to Shareholders - Business Wire

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech, CureVac Agree to All-stock Purchase Deal - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Oracle and CureVac rise premarket; Boeing and GameStop fall By Investing.com - Investing.com UK

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech to Buy CureVac in All-Stock Deal - marketscreener.com

Jun 12, 2025

Curevac N V Azioni (CVAC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Capitalizzazione:     |  Volume (24 ore):